{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:13:48Z","timestamp":1793643228990,"version":"4.5.1"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>It has been reported that the imbalance of gut microbiota is involved in the pathogenesis of psoriasis. We retrieved randomized placebo-controlled trials to evaluate the efficacy and safety of probiotic administration in the treatment of psoriasis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The outcomes were changes in Psoriasis Area and Severity Index (PASI), Dermatology Life Quality Index (DLQI), and serum inflammatory indicators after treatment, and adverse events (AEs). Risk ratios (RRs) and mean differences (MDs) were calculated using random or fixed effects model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Seven qualified studies were identified in our study. The pooled percentage of patients with \u226575% reduction from baseline in PASI was higher in the probiotic group than that in the placebo group (33.57% vs. 23.61%; RR 1.40, 95% CI 0.98\u20131.98, <jats:italic>p<\/jats:italic>\u2009=\u20090.06). Compared with the placebo group, the PASI (MD \u22123.09, 95% CI \u22125.04 to \u22120.74, <jats:italic>p<\/jats:italic>\u2009=\u20090.01) and CRP level (MD \u22122.36, 95% CI \u22122.77 to \u22121.95, <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.0001) were significantly reduced in the probiotic group. There was no significant difference in DLQI (MD \u22121.45, 95% CI \u22126.72 to 3.82, <jats:italic>p<\/jats:italic>\u2009=\u20090.59) and AEs (RR 0.68, 95% CI 0.37\u20131.25, <jats:italic>p<\/jats:italic>\u2009=\u20090.22) between the two groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Oral administration of probiotics can improve psoriasis; however, large randomized controlled trials are needed to support this conclusion.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic review registration<\/jats:title><jats:p>PROSPERO, identifier CRD42024506286, <jats:ext-link>https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42024506286<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2024.1448626","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T04:47:35Z","timestamp":1725598055000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["The efficacy and safety of probiotics in the adjuvant treatment of psoriasis: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.3389","volume":"11","author":[{"given":"Yiran","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanhui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,6]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/bs.acc.2020.04.004","article-title":"Cytokines in psoriasis","volume":"100","author":"de Alcantara","year":"2021","journal-title":"Adv Clin Chem"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3389\/fimmu.2020.00575","article-title":"Intestinal flora and disease mutually shape the regional immune system in the intestinal tract","volume":"11","author":"Zhou","year":"2020","journal-title":"Front Immunol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000496426","article-title":"Beneficial effects of probiotic consumption on the immune system","volume":"74","author":"Maldonado Galdeano","year":"2019","journal-title":"Ann Nutr Metab"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2096995","DOI":"10.1080\/19490976.2022.2096995","article-title":"Impact of gut microbiome on skin health: gut-skin axis observed through the lenses of therapeutics and skin diseases","volume":"14","author":"Mahmud","year":"2022","journal-title":"Gut Microbes"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.3390\/nu14142970","article-title":"Gut microbiota in psoriasis","volume":"14","author":"Buha\u0219","year":"2022","journal-title":"Nutrients"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.3390\/ijms22083998","article-title":"Alterations of the skin and gut microbiome in psoriasis and psoriatic arthritis","volume":"22","author":"Olejniczak-Staruch","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.3390\/ijms22094529","article-title":"Psoriasis and gut microbiome-current state of art","volume":"22","author":"Polak","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1136\/ard-2022-223389","article-title":"Alterations in the cutaneous microbiome of patients with psoriasis and psoriatic arthritis reveal similarities between non-lesional and lesional skin","volume":"82","author":"Boix-Amor\u00f3s","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1111\/exd.14528","article-title":"Dysbiosis of nail microbiome in patients with psoriasis","volume":"31","author":"Wang","year":"2022","journal-title":"Exp Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41392-022-01219-0","article-title":"Intestinal dysbiosis exacerbates the pathogenesis of psoriasis-like phenotype through changes in fatty acid metabolism","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.3390\/nu15081952","article-title":"Dose-response efficacy and mechanisms of orally administered bifidobacterium breve CCFM683 on IMQ-induced psoriasis in mice","volume":"15","author":"Chen","year":"2023","journal-title":"Nutrients"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"637","DOI":"10.36849\/jdd.6237","article-title":"Probiotics supplementation improves quality of life, clinical symptoms, and inflammatory status in patients with psoriasis","volume":"21","author":"Moludi","year":"2022","journal-title":"J Drugs Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1007\/s00403-023-02553-1","article-title":"Efficacy of an adjuvant Lactobacillus rhamnosus formula in improving skin lesions as assessed by PASI in patients with plaque psoriasis from a university-affiliated, tertiary-referral hospital in S\u00e3o Paulo (Brazil): a parallel, double-blind, randomized clinical trial","volume":"315","author":"Suriano","year":"2023","journal-title":"Arch Dermatol Res"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"7552546","DOI":"10.1155\/2021\/7552546","article-title":"The effectiveness and safety of probiotic supplements for psoriasis: a systematic review and meta-analysis of randomized controlled trials and preclinical trials","volume":"2021","author":"Zeng","year":"2021","journal-title":"J Immunol Res"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.1002\/9781119536604.ch13","article-title":"Assessing risk of bias due to missing results in a synthesis","volume-title":"Cochrane handbook for systematic reviews of interventions version 6.0 (updated July 2019) Cochrane","author":"Page","year":"2019"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.2340\/00015555-3305","article-title":"Efficacy and safety of oral administration of a mixture of probiotic strains in patients with psoriasis: a randomized controlled clinical trial","volume":"99","author":"Navarro-L\u00f3pez","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.clnesp.2021.09.004","article-title":"Probiotic supplementation improves clinical outcomes and quality of life indicators in patients with plaque psoriasis: a randomized double-blind clinical trial","volume":"46","author":"Moludi","year":"2021","journal-title":"Clin Nutr ESPEN"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"4549134","DOI":"10.1155\/2022\/4549134","article-title":"The efficacy of Lactocare\u00ae synbiotic on the clinical symptoms in patients with psoriasis: a randomized, double-blind, placebo-controlled clinical trial","volume":"2022","author":"Akbarzadeh","year":"2022","journal-title":"Dermatol Res Pract"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"325","DOI":"10.4161\/gmic.25487","article-title":"Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut","volume":"4","author":"Groeger","year":"2013","journal-title":"Gut Microbes"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/24755303221142296","article-title":"The role of probiotics as an adjunctive therapy in psoriasis","volume":"8","author":"Gilli","year":"2022","journal-title":"J Psoriasis Psoriatic Arthritis"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1297240","DOI":"10.3389\/fimmu.2024.1297240","article-title":"The associations between gut microbiota and inflammatory skin diseases: a bi-directional two-sample Mendelian randomization study","volume":"15","author":"Zhong","year":"2024","journal-title":"Front Immunol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"e0115423","DOI":"10.1128\/spectrum.01154-23","article-title":"Eubacterium rectale is a potential marker of altered gut microbiota in psoriasis and psoriatic arthritis","volume":"12","author":"Xiao","year":"2024","journal-title":"Microbiol Spectr"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e18023","DOI":"10.1111\/jcmm.18023","article-title":"Psoriasis and gut microbiota: a Mendelian randomization study","volume":"28","author":"Wu","year":"2024","journal-title":"J Cell Mol Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"8831","DOI":"10.1038\/s41598-024-59603-5","article-title":"Assessing causal relationships between gut microbiota and psoriasis: evidence from two sample Mendelian randomization analysis","volume":"14","author":"Li","year":"2024","journal-title":"Sci Rep"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1136\/annrheumdis-2020-219511","article-title":"Safety and efficacy of faecal microbiota transplantation for active peripheral psoriatic arthritis: an exploratory randomised placebo-controlled trial","volume":"80","author":"Kragsnaes","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1344963","DOI":"10.3389\/fimmu.2024.1344963","article-title":"IL-17A inhibitors alleviate psoriasis with concomitant restoration of intestinal\/skin microbiota homeostasis and altered microbiota function","volume":"15","author":"Zhao","year":"2024","journal-title":"Front Immunol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s00403-024-03024-x","article-title":"Modulation of the skin and gut microbiome by psoriasis treatment: a comprehensive systematic review","volume":"316","author":"Korneev","year":"2024","journal-title":"Arch Dermatol Res"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"101494","DOI":"10.1016\/j.berh.2020.101494","article-title":"The gut microbiome in psoriasis and psoriatic arthritis","volume":"33","author":"Myers","year":"2019","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3390\/pathogens9060463","article-title":"Gut microbiome in psoriasis: an updated review","volume":"9","author":"Sikora","year":"2020","journal-title":"Pathogens"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"754","DOI":"10.7150\/thno.51154","article-title":"Metabolomic profiling reveals amino acid and carnitine alterations as metabolic signatures in psoriasis","volume":"11","author":"Chen","year":"2021","journal-title":"Theranostics"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"43588","DOI":"10.1021\/acsami.9b15668","article-title":"Hyaluronic acid-based dissolving microneedle patch loaded with methotrexate for improved treatment of psoriasis","volume":"11","author":"Du","year":"2019","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.toxicon.2017.10.016","article-title":"Exotoxins and endotoxins: inducers of inflammatory cytokines","volume":"149","author":"Cavaillon","year":"2018","journal-title":"Toxicon"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.fct.2011.11.027","article-title":"Effect of garlic sulfur compounds on neutrophil infiltration and damage to the intestinal mucosa by endotoxin in rats","volume":"50","author":"Lee","year":"2012","journal-title":"Food Chem Toxicol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.3390\/ijms24043494","article-title":"Bacterial metabolites: a link between gut microbiota and dermatological diseases","volume":"24","author":"Stec","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"3880","DOI":"10.3390\/jcm10173880","article-title":"The defect in regulatory T cells in psoriasis and therapeutic approaches","volume":"10","author":"Kanda","year":"2021","journal-title":"J Clin Med"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41588-019-0350-x","article-title":"Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases","volume":"51","author":"Sanna","year":"2019","journal-title":"Nat Genet"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/jdv.12257","article-title":"C-reactive protein in psoriasis: a review of the literature","volume":"28","author":"Beygi","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1111\/j.1365-4632.2010.04761.x","article-title":"High-sensitivity C-reactive protein in psoriasis","volume":"51","author":"Nisa","year":"2012","journal-title":"Int J Dermatol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.jid.2016.11.022","article-title":"IL-6 differs from TNF-\u03b1: unpredicted clinical effects caused by IL-6 blockade in psoriasis","volume":"137","author":"Blauvelt","year":"2017","journal-title":"J Invest Dermatol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.abd.2023.03.002","article-title":"Elevated serum IL-6 levels predict treatment interruption in patients with moderate to severe psoriasis: a 6-year real-world cohort study","volume":"99","author":"Alves","year":"2024","journal-title":"An Bras Dermatol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1448626\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T15:53:10Z","timestamp":1727365990000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1448626\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,6]]},"references-count":42,"alternative-id":["10.3389\/fmed.2024.1448626"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1448626","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,6]]},"article-number":"1448626"}}